Efficacy, Safety, and Retention Rate of Extended-Release Divalproex Versus Conventional Delayed-Release Divalproex: A Meta-Analysis of Controlled Clinical Trials

Purpose: A novel once-daily divalproex-extended release (ER) dose formulation has been developed; this formulation prolongs the therapeutic serum levels of the drug, compared with the twice-daily conventional divalproex-delayed release (DR) formulation. This study aimed to systematically examine and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chen Qi, Li, Hong Yan, Wan, Yong, Bai, Xue Yang, Gan, Lu, Wang, Juan, Sun, Hong Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037144/
https://www.ncbi.nlm.nih.gov/pubmed/35479307
http://dx.doi.org/10.3389/fphar.2022.811017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037144/
https://www.ncbi.nlm.nih.gov/pubmed/35479307
http://dx.doi.org/10.3389/fphar.2022.811017

Ejemplares similares